Compare BBIO & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBIO | ULS |
|---|---|---|
| Founded | 2015 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 14.2B |
| IPO Year | 2019 | 2023 |
| Metric | BBIO | ULS |
|---|---|---|
| Price | $65.88 | $81.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 8 |
| Target Price | $79.91 | ★ $88.85 |
| AVG Volume (30 Days) | ★ 2.8M | 1.0M |
| Earning Date | 05-22-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.60 |
| Revenue | $502,076,000.00 | ★ $3,053,000,000.00 |
| Revenue This Year | $85.55 | $6.39 |
| Revenue Next Year | $71.10 | $5.88 |
| P/E Ratio | ★ N/A | $50.43 |
| Revenue Growth | ★ 126.26 | 6.38 |
| 52 Week Low | $28.33 | $49.34 |
| 52 Week High | $84.94 | $91.95 |
| Indicator | BBIO | ULS |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 60.73 |
| Support Level | $61.54 | $76.51 |
| Resistance Level | $68.71 | $86.94 |
| Average True Range (ATR) | 4.46 | 3.07 |
| MACD | -0.77 | 1.41 |
| Stochastic Oscillator | 17.00 | 81.59 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.